These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 15994962

  • 1. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
    Zhou Y, Brattain MG.
    Cancer Res; 2005 Jul 01; 65(13):5848-56. PubMed ID: 15994962
    [Abstract] [Full Text] [Related]

  • 2. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG.
    Cancer Res; 2006 Jan 01; 66(1):404-11. PubMed ID: 16397255
    [Abstract] [Full Text] [Related]

  • 3. Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells.
    Choi S, Choi Y, Dat NT, Hwangbo C, Lee JJ, Lee JH.
    Cancer Lett; 2010 Jul 01; 293(1):23-30. PubMed ID: 20056314
    [Abstract] [Full Text] [Related]

  • 4. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.
    Cancer Res; 2004 Jul 15; 64(14):4931-41. PubMed ID: 15256466
    [Abstract] [Full Text] [Related]

  • 5. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 15; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
    Kang N, Zhang JH, Qiu F, Tashiro S, Onodera S, Ikejima T.
    Cancer Lett; 2010 Aug 28; 294(2):147-58. PubMed ID: 20202741
    [Abstract] [Full Text] [Related]

  • 7. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K, Shin-ya T, Nishio K, Ito F.
    FEBS J; 2009 Mar 28; 276(5):1255-65. PubMed ID: 19175673
    [Abstract] [Full Text] [Related]

  • 8. Novel irreversible EGFR tyrosine kinase inhibitor 324674 sensitizes human colon carcinoma HT29 and SW480 cells to apoptosis by blocking the EGFR pathway.
    Yu Z, Cui B, Jin Y, Chen H, Wang X.
    Biochem Biophys Res Commun; 2011 Aug 12; 411(4):751-6. PubMed ID: 21782788
    [Abstract] [Full Text] [Related]

  • 9. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M.
    Mol Cancer Res; 2004 Sep 12; 2(9):514-22. PubMed ID: 15383630
    [Abstract] [Full Text] [Related]

  • 10. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG, Du Q, Fang WG, Jin ML, Tian XX.
    Int J Oncol; 2008 Sep 12; 33(3):595-602. PubMed ID: 18695891
    [Abstract] [Full Text] [Related]

  • 11. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer.
    Lanza-Jacoby S, Burd R, Rosato FE, McGuire K, Little J, Nougbilly N, Miller S.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6161-9. PubMed ID: 17062693
    [Abstract] [Full Text] [Related]

  • 12. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.
    Mol Cancer Res; 2007 Apr 15; 5(4):393-401. PubMed ID: 17426253
    [Abstract] [Full Text] [Related]

  • 13. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Apr 15; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 14. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

  • 15. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
    McCubrey JA, Shelton JG, Steelman LS, Franklin RA, Sreevalsan T, McMahon M.
    Oncogene; 2004 Oct 14; 23(47):7810-20. PubMed ID: 15361836
    [Abstract] [Full Text] [Related]

  • 16. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
    Witters LM, Witkoski A, Planas-Silva MD, Berger M, Viallet J, Lipton A.
    Oncol Rep; 2007 Feb 14; 17(2):465-9. PubMed ID: 17203189
    [Abstract] [Full Text] [Related]

  • 17. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
    Younes MN, Yazici YD, Kim S, Jasser SA, El-Naggar AK, Myers JN.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3425-34. PubMed ID: 16740767
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478.
    Weyergang A, Kaalhus O, Berg K.
    Photochem Photobiol Sci; 2008 Sep 01; 7(9):1032-40. PubMed ID: 18754049
    [Abstract] [Full Text] [Related]

  • 19. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.
    Gulliford TJ, Huang GC, Ouyang X, Epstein RJ.
    Oncogene; 1997 Oct 01; 15(18):2219-23. PubMed ID: 9393980
    [Abstract] [Full Text] [Related]

  • 20. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
    Emanuel SL, Hughes TV, Adams M, Rugg CA, Fuentes-Pesquera A, Connolly PJ, Pandey N, Moreno-Mazza S, Butler J, Borowski V, Middleton SA, Gruninger RH, Story JR, Napier C, Hollister B, Greenberger LM.
    Mol Pharmacol; 2008 Feb 01; 73(2):338-48. PubMed ID: 17975007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.